The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serreze, D. V.
Right arrow Articles by Leiter, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serreze, D. V.
Right arrow Articles by Leiter, E. H.

The Journal of Immunology, Vol 140, Issue 11 3801-3807, Copyright © 1988 by American Association of Immunologists


ARTICLES

Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies

DV Serreze and EH Leiter
Jackson Laboratory, Bar Harbor, ME 04609.

Nonobese diabetic (NOD) is an inbred mouse strain susceptible to development of T cell-mediated autoimmune diabetes. The strain is characterized by high percentages of T lymphocytes in lymphoid organs. The syngeneic mixed lymphocyte reaction (SMLR), a T cell response to self MHC class II Ag, is reportedly involved in the generation of a number of immunoregulatory cells, including suppressor inducers. A severely depressed SMLR characteristic of certain other autoimmune strains was found in NOD but not in nonautoimmune SWR/Bm mice. Moreover, IL-2 produced by NOD T cells at day 6 in an SMLR was at least one hundredfold reduced compared with SWR, and NOD T cells harvested from an SMLR at day 6 were functionally defective when tested for ability to induce suppression of an allogeneic MLR. However, functionally competent suppressor T cells were generated in NOD splenic leukocyte cultures in response to Con A, and IL-2 release from these was equivalent to that released by Con A-stimulated SWR splenocytes. A deficiency in cytokine release was not limited to IL-2, because peritoneal exudate cells from NOD exhibited a greatly diminished sensitivity to LPS-stimulated IL-1 release in comparison to SWR mice. IL-2 supplementation both in vitro and in vivo restored the ability of NOD T cells to respond in a SMLR, with production of cells capable of inducing suppression. Like SMLR-activated T cells from untreated SWR controls, SMLR blasts from IL-2-treated NOD mice were enriched for the L3T4 phenotype. IL-1 supplementation in vitro resulted in partial restoration of T suppressor activation in a SMLR. The depressed SMLR exhibited by NOD mice was apparently a stimulator cell dysfunction, because NOD stimulator cells failed to activate T cells from (SWR x NOD)F1 mice, whereas stimulators from SWR or F1 mice were capable of doing so. Collectively, these results suggest a defect in suppressor cell activation rather than an absence of this immunoregulatory cell population.


This article has been cited by other articles:


Home page
DiabetesHome page
S. D. Burke, H. Dong, A. D. Hazan, and B. A. Croy
Aberrant Endometrial Features of Pregnancy in Diabetic NOD Mice
Diabetes, December 1, 2007; 56(12): 2919 - 2926.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. S. Mohamood, M. L. Guler, Z. Xiao, D. Zheng, A. Hess, Y. Wang, H. Yagita, J. P. Schneck, and A. R. A. Hamad
Protection from Autoimmune Diabetes and T-Cell Lymphoproliferation Induced by FasL Mutation Are Differentially Regulated and Can Be Uncoupled Pharmacologically
Am. J. Pathol., July 1, 2007; 171(1): 97 - 106.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. V. Serreze, M. A. Osborne, Y.-G. Chen, H. D. Chapman, T. Pearson, M. A. Brehm, and D. L. Greiner
Partial versus Full Allogeneic Hemopoietic Chimerization Is a Preferential Means to Inhibit Type 1 Diabetes as the Latter Induces Generalized Immunosuppression
J. Immunol., November 15, 2006; 177(10): 6675 - 6684.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Alard, J. N. Manirarora, S. A. Parnell, J. L. Hudkins, S. L. Clark, and M. M. Kosiewicz
Deficiency in NOD Antigen-Presenting Cell Function May Be Responsible for Suboptimal CD4+CD25+ T-Cell-Mediated Regulation and Type 1 Diabetes Development in NOD Mice.
Diabetes, July 1, 2006; 55(7): 2098 - 2105.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C.-H. Lee, Y.-G. Chen, J. Chen, P. C. Reifsnyder, D. V. Serreze, M. Clare-Salzler, M. Rodriguez, C. Wasserfall, M. A. Atkinson, and E. H. Leiter
Novel Leptin Receptor Mutation in NOD/LtJ Mice Suppresses Type 1 Diabetes Progression: II. Immunologic Analysis
Diabetes, January 1, 2006; 55(1): 171 - 178.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. J. Steptoe, J. M. Ritchie, L. K. Jones, and L. C. Harrison
Autoimmune Diabetes Is Suppressed by Transfer of Proinsulin-Encoding Gr-1+ Myeloid Progenitor Cells That Differentiate In Vivo Into Resting Dendritic Cells
Diabetes, February 1, 2005; 54(2): 434 - 442.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-G. Chen, C.-M. Choisy-Rossi, T. M. Holl, H. D. Chapman, G. S. Besra, S. A. Porcelli, D. J. Shaffer, D. Roopenian, S. B. Wilson, and D. V. Serreze
Activated NKT Cells Inhibit Autoimmune Diabetes through Tolerogenic Recruitment of Dendritic Cells to Pancreatic Lymph Nodes
J. Immunol., February 1, 2005; 174(3): 1196 - 1204.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Fan, A. Longacre, F. Meng, V. Patel, K. Hsiao, J. S. Koh, and J. S. Levine
Cytokine Dysregulation Induced by Apoptotic Cells Is a Shared Characteristic of Macrophages from Nonobese Diabetic and Systemic Lupus Erythematosus-Prone Mice
J. Immunol., April 15, 2004; 172(8): 4834 - 4843.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. A. Silveira, J. Dombrowsky, E. Johnson, H. D. Chapman, D. Nemazee, and D. V. Serreze
B Cell Selection Defects Underlie the Development of Diabetogenic APCs in Nonobese Diabetic Mice
J. Immunol., April 15, 2004; 172(8): 5086 - 5094.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Pearson, T. G. Markees, D. V. Serreze, M. A. Pierce, M. P. Marron, L. S. Wicker, L. B. Peterson, L. D. Shultz, J. P. Mordes, A. A. Rossini, et al.
Genetic Disassociation of Autoimmunity and Resistance to Costimulation Blockade-Induced Transplantation Tolerance in Nonobese Diabetic Mice
J. Immunol., July 1, 2003; 171(1): 185 - 195.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. V. Serreze, M. A. Pierce, C. M. Post, H. D. Chapman, H. Savage, R. T. Bronson, P. B. Rothman, and G. A. Cox
Paralytic Autoimmune Myositis Develops in Nonobese Diabetic Mice Made Th1 Cytokine-Deficient by Expression of an IFN-{gamma} Receptor {beta}-Chain Transgene
J. Immunol., March 1, 2003; 170(5): 2742 - 2749.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. P. Berzins, E. S. Venanzi, C. Benoist, and D. Mathis
T-Cell Compartments of Prediabetic NOD Mice
Diabetes, February 1, 2003; 52(2): 327 - 334.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. Yang, M. Bao, and J.-W. Yoon
Intrinsic Defects in the T-Cell Lineage Results in Natural Killer T-Cell Deficiency and the Development of Diabetes in the Nonobese Diabetic Mouse
Diabetes, December 1, 2001; 50(12): 2691 - 2699.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. Quinn, M. Melo, D. Ethell, and Eli. E. Sercarz
Relative resistance to nasally induced tolerance in non-obese diabetic mice but not other I-Ag7-expressing mouse strains
Int. Immunol., October 1, 2001; 13(10): 1321 - 1333.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. T. C. Kreuwel, J. A. Biggs, I. M. Pilip, E. G. Pamer, D. Lo, and L. A. Sherman
Defective CD8+ T Cell Peripheral Tolerance in Nonobese Diabetic Mice
J. Immunol., July 15, 2001; 167(2): 1112 - 1117.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. G. A. Delemarre, P. G. Hoogeveen, M. de Haan-Meulman, P. J. Simons, and H. A. Drexhage
Homotypic cluster formation of dendritic cells, a close correlate of their state of maturation. Defects in the biobreeding diabetes-prone rat
J. Leukoc. Biol., March 1, 2001; 69(3): 373 - 380.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
D. V. Serreze, H. D. Chapman, C. M. Post, E. A. Johnson, W. L. Suarez-Pinzon, and A. Rabinovitch
Th1 to Th2 Cytokine Shifts in Nonobese Diabetic Mice: Sometimes an Outcome, Rather Than the Cause, of Diabetes Resistance Elicited by Immunostimulation
J. Immunol., January 15, 2001; 166(2): 1352 - 1359.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Trembleau, G. Penna, S. Gregori, G. Magistrelli, A. Isacchi, and L. Adorini
Early Th1 Response in Unprimed Nonobese Diabetic Mice to the Tyrosine Phosphatase-Like Insulinoma-Associated Protein 2, an Autoantigen in Type 1 Diabetes
J. Immunol., December 15, 2000; 165(12): 6748 - 6755.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. G. A. Delemarre, P. J. Simons, H. J. de Heer, and H. A. Drexhage
Signs of Immaturity of Splenic Dendritic Cells from the Autoimmune Prone Biobreeding Rat: Consequences for the In Vitro Expansion of Regulator and Effector T Cells
J. Immunol., February 1, 1999; 162(3): 1795 - 1801.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. V. Serreze, S. A. Fleming, H. D. Chapman, S. D. Richard, E. H. Leiter, and R. M. Tisch
B Lymphocytes Are Critical Antigen-Presenting Cells for the Initiation of T Cell-Mediated Autoimmune Diabetes in Nonobese Diabetic Mice
J. Immunol., October 15, 1998; 161(8): 3912 - 3918.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Takahashi, M. C. Honeyman, and L. C. Harrison
Impaired Yield, Phenotype, and Function of Monocyte-Derived Dendritic Cells in Humans at Risk for Insulin-Dependent Diabetes
J. Immunol., September 1, 1998; 161(5): 2629 - 2635.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
D. L. Greiner, R. A. Hesselton, and L. D. Shultz
SCID Mouse Models of Human Stem Cell Engraftment
Stem Cells, May 1, 1998; 16(3): 166 - 177.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
D. V. Serreze, M. Bridgett, H. D. Chapman, E. Chen, S. D. Richard, and E. H. Leiter
Subcongenic Analysis of the Idd13 Locus in NOD/Lt Mice: Evidence for Several Susceptibility Genes Including a Possible Diabetogenic Role for {beta}2-Microglobulin
J. Immunol., February 1, 1998; 160(3): 1472 - 1478.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. M. Casteels, C. Mathieu, M. Waer, D. Valckx, L. Overbergh, J. M. Laureys, and R. Bouillon
Prevention of Type I Diabetes in Nonobese Diabetic Mice by Late Intervention with Nonhypercalcemic Analogs of 1,25-Dihydroxyvitamin D3 in Combination with a Short Induction Course of Cyclosporin A
Endocrinology, January 1, 1998; 139(1): 95 - 102.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. Prins, J. Todd, N. Rodrigues, S Ghosh, P. Hogarth, L. Wicker, E Gaffney, P. Podolin, P. Fischer, A Sirotina, et al.
Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice
Science, April 30, 1993; 260(5108): 695 - 698.
[Abstract] [PDF]


Home page
ScienceHome page
D. Faustman, X. Li, H. Y. Lin, R. Huang, and J. Guo
Response
Science, June 26, 1992; 256(5065): 1830 - 1831.
[PDF]


Home page
ScienceHome page
D Faustman, X. Li, H. Lin, Y. Fu, G Eisenbarth, J Avruch, and J Guo
Linkage of faulty major histocompatibility complex class I to autoimmune diabetes
Science, December 20, 1991; 254(5039): 1756 - 1761.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.